NAT10 and chronic kidney disease: We compared patients with CHD who had different HALP levels and found that age, gender, smoking, dyslipidemia, CKD, HB, ALB, lymphocyte, platelet, WBC, monocyte, treatment for anemia, anticonvulsants, and adrenal cortical steroids were all significantly different among the four HALP score groups (all P < 0.05).